ENHO and prediabetes syndrome: In this connection, the decreased levels of adropin in post-STEMI individuals with newly diagnosed prediabetes can be considered a new pathogenetic factor contributing to microvascular inflammation, plaque instability, endothelial dysfunction, acceleration of atherosclerosis and post-conditioning [29,30,32].